B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

LYPLA1

MOLECULAR TARGET

lysophospholipase 1

UniProt: O75608NCBI Gene: 104341 compounds

LYPLA1 (lysophospholipase 1) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting LYPLA1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1palmostatin b1.393

About LYPLA1 as a Drug Target

LYPLA1 (lysophospholipase 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented LYPLA1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

LYPLA1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.